HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sinisa Gradinac Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frazier, O.H. Articles by Radovancevic, B. Search for Related Content PubMed PubMed Citation Articles by Frazier, O.H. Articles by Radovancevic, B. Related Collections Related Article

Ann Thorac Surg 2000;69:1836-1841
© 2000 The Society of Thoracic Surgeons

---

Original articles: Cardiovascular

Partial left ventriculectomy: which patients can be expected to benefit?

^a Cardiovascular Research Laboratories, Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston, Texas, USA
^b Cardiovascular Research Laboratories, Department of Pathology, Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston, Texas, USA
^c Department of Surgery, Dedinje Cardiovascular Institute, Belgrade, Yugoslavia
^d Department of Pathology, Dedinje Cardiovascular Institute, Belgrade, Yugoslavia
^e Department of Cardiology, Dedinje Cardiovascular Institute, Belgrade, Yugoslavia

Address reprint requests to Dr Frazier, Texas Heart Institute, PO Box 20345, MC 3–147, Houston, TX 77225–0345
e-mail: mmallia{at}heart.thi.tmc.edu

Background. Although some patients with end-stage heart disease will benefit from a partial left ventriculectomy, no criteria have been found for identifying this group preoperatively. Our experience with partial left ventriculectomy at two institutions—the Texas Heart Institute in Houston, TX, USA, and Dedinje Cardiovascular Institute in Belgrade, Yugoslavia—showed a higher survival rate and better postoperative myocardial function in the Yugoslavian patients.

Methods. We reviewed data from 42 patients (21 at each center) who had idiopathic cardiomyopathy, a left ventricular end-diastolic dimension of more than 70 mm, wall thickness of 1 cm or greater, and New York Heart Association class III or IV symptoms. The only significant difference in preoperative status between the two groups was duration of symptoms. Histologic specimens, blinded as to origin, were graded with regard to myocyte hypertrophy, cytoplasmic vacuolation, and fibrosis. Computer-assisted myocyte and nuclear morphometry was also performed.

Results. Immediately postoperatively, there were no significant intergroup differences in the reduction in cardiac dimension or in corrections of mitral regurgitation. During 6-month follow-up, however, the Texas Heart Institute patients had a lower cardiac index (1.8 versus 3.0 L·min^-1·m^-2; p = 0.001) and left ventricular ejection fraction (24% versus 34%; p = 0.006) than the Dedinje Cardiovascular Institute patients. The Texas Heart Institute patients differed from the Dedinje Cardiovascular Institute patients in the degree of severe or moderate changes in myocyte hypertrophy (90% versus 29%; p = 0.0003) and fibrosis (71% versus 29%; p = 0.006), as well as in the measurements of median myocyte diameter (35 ± 7 µm versus 27 ± 4 µm; p = 0.0002) and median nuclear size (15 ± 4 µm versus 12 ± 2 µm; p = 0.0029).

Conclusions. In the Texas Heart Institute patients, the significant intergroup difference in clinical outcome may have been related to increased myocyte hypertrophy and fibrosis. Further studies should be performed to determine the usefulness of these criteria in selecting patients for partial left ventriculectomy.

Related Article

Invited commentary

Noedir A.G. Stolf
Ann. Thorac. Surg. 2000 69: 1841. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				H. Suma, H. Tanabe, T. Uejima, S. Suzuki, T. Horii, and T. Isomura Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 912 - 916. [Abstract] [Full Text] [PDF]

				R. Ascione, P. Wilde, and G. D. Angelini Left ventricular volume reduction MMCTS, June 28, 2005; 2005(0628): 760. [Abstract] [Full Text] [PDF]

				E. N. Soo, R. Ascione, P. Wilde, and G. D. Angelini Eight years survival after partial left ventriculectomy Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 724 - 725. [Abstract] [Full Text] [PDF]

				R. M. Setser, J. M. Kasper, M. L. Lieber, R. C. Starling, P. M. McCarthy, and R. D. White Persistent abnormal left ventricular systolic torsion in dilated cardiomyopathy after partial left ventriculectomy J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 48 - 55. [Abstract] [Full Text] [PDF]

				A. Franco-Cereceda, P. M. McCarthy, E. H. Blackstone, K. J. Hoercher, J. A. White, J. B. Young, and R. C. Starling Partial left ventriculectomy for dilated cardiomyopathy: Is this an alternative to transplantation? J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 879 - 893. [Abstract] [Full Text] [PDF]

				L. F. P. Moreira, N. A.G. Stolf, M. d. L. Higuchi, F. Bacal, E. A. Bocchi, and S. A. Oliveira Current perspectives of partial left ventriculectomy in the treatment of dilated cardiomyopathy Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 54 - 60. [Abstract] [Full Text] [PDF]